ArticleMikrochimica acta2026
Selective determination of 6-mercaptopurine by a platinum nanoparticle-enhanced dsDNA-based electrochemical biosensor.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
An electrochemical biosensor is presented utilizing short double-stranded DNA (dsDNA 5`-GGCAGGACGGAG-3`) with proven selective interaction with 6-mercaptopurine (6MP). Two biosensor designs were developed: one based on screen-printed graphite electrodes (GSPEs) with an adsorbed dsDNA layer (GSPE/dsDNA) and another one incorporating platinum nanoparticles to enhance the electrochemical response (GSPE/Pt-Cys-dsDNA). The developed GSPE/dsDNA and GSPE/Pt-Cys-dsDNA biosensors demonstrated a linear response within the nanomolar concentration range, from 200 to 1000 nM and from 2 to 75 nM, respectively. Selectivity studies confirmed effective discrimination of 6MP from common biointerferents and other coadministered drugs. Ultimately, the biosensor’s analytical performance was verified in artificial urine samples spiked with 6MP. The results from the biosensor with the Pt nanoparticles closely matched those from the reference HPLC method (±7%), confirming its accuracy and reliability. Overall, this work demonstrates how interactions of specific dsDNA sequence with small molecule can be translated into a robust electrochemical microanalytical tool for selective nanomolar determination of 6-mercaptopurine. This is the first reported DNA-based electrochemical approach for selective 6MP sensing, providing a rapid and cost-effective alternative to traditional instrumental methods.
Indexed as
Identifiers
41931145What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.